New CDC Recommendations for Postpartum Contraceptive Use
New recommendations by the CDC state that postpartum women should not use combined hormonal contraceptives during the first 21 days after delivery because of high risk for venous thromboembolism (VTE) during this period.
New recommendations by the CDC state that postpartum women should not use combined hormonal contraceptives during the first 21 days after delivery because of high risk for venous thromboembolism (VTE) during this period. During days 21 to 42 postpartum, women with no risk factors for VTE can initiate combined hormonal contraceptives, but women with risk factors for VTE, such as previous VTE or recent cesarean delivery, should avoid these types of contraceptives. After 42 days postpartum, with respect to use of combined hormonal contraceptives, no restrictions on the the basis of postpartum status apply.
More Information
Global Library of Women’s Medicine: Postpartum ContraceptionCDC Updates Guidelines for Postpartum Contraceptive Use
References:
Reference
1. Centers for Disease Control and Prevention. Update to CDC’s US medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period. MMWR. 2011;60:878-883.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Contemporary understanding of breast cancer risk with combined oral contraceptives
April 2nd 2024Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
Read More
